Hepatitis C Cooperative Research Centers (U19)

The summary for the Hepatitis C Cooperative Research Centers (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Hepatitis C Cooperative Research Centers (U19): Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) invites applications for Hepatitis C Cooperative Research Centers (HepC CRCs). These Centers will advance the understanding of hepatitis C virus (HCV)-host interactions, specifically the host immune response to infection, and the factors that tilt the balance between spontaneous or therapy-induced clearance and chronic persistence of HCV. Experimental observations will be validated and clinical relevance demonstrated, in appropriate, well-defined, patient cohorts. The underlying mission of the Centers is to close the gaps that currently exist with regard to defining successful immune response and identifying new targets for antiviral drugs, vaccines, and other therapeutic strategies for the prevention or treatment of acute and chronic HCV infection. Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH multi-project (U19) cooperative agreement grant mechanism. Funds Available and Anticipated Number of Awards. The NIAID expect(s) to award $4 million in total costs in response to this FOA, in FY 2010, to fund 4-5 new and/or renewal grants.

Federal Grant Title:	Hepatitis C Cooperative Research Centers (U19)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-09-025
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Aug 06, 2009
Original Application Deadline:	Aug 06, 2009
Posted Date:	Apr 07, 2009
Creation Date:	Apr 07, 2009
Archive Date:	Sep 06, 2009
Total Program Funding:	$4,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed); • Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed); • Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not A...; • Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Cl...; • Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed); • Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed); • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...; • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...